Literature DB >> 1672796

Hypothalamic NE release and cardiovascular response to NaCl in sinoaortic-denervated rats.

T Nakata1, W Berard, E Kogosov, N Alexander.   

Abstract

We determined the activity of noradrenergic neurons in the nucleus of the posterior hypothalamus (PH) of sinoaortic-denervated (SAD) and sham-operated (SO) rats during cardiovascular responses to intravenous (iv) or local brain dialysis of NaCl. PH extracellular norepinephrine (NE) was collected by microdialysis from freely moving rats, and dialysate NE was measured by radioenzymatic assay. Three days after SAD or SO, mean arterial pressure (MAP) and heart rate (HR) were significantly higher in SAD rats than SO rats. Basal levels of PH dialysate were also significantly elevated in SAD rats. Local dialysis of PH with hypertonic NaCl produced pressor and tachycardiac responses coupled with increased NE release in PH in both groups, but the increases in MAP and dialysate NE were larger in SAD than SO rats. Ganglionic blockade with iv hexamethonium elicited significantly larger depressor and bradycardiac responses in SAD rats, whereas the percent increase of dialysate NE was smaller than that of SO rats. The iv infusion of hypertonic NaCl produced larger pressor responses in SAD than SO rats and a significant increase in dialysate NE from PH of SAD but not SO rats. These findings indicate that 1) PH is an important site of NaCl action and 2) noradrenergic input in PH receives tonic inhibitory input from baroreflex pathways and contributes to cardiovascular hyperactivity and hypertension in SAD rats.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672796     DOI: 10.1152/ajpregu.1991.260.4.R733

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  1 in total

1.  Use of chlorisondamine to assess the neurogenic contribution to blood pressure in mice: An evaluation of method.

Authors:  Lucas Ac Souza; Silvana G Cooper; Caleb J Worker; Pratish Thakore; Yumei Feng Earley
Journal:  Physiol Rep       Date:  2021-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.